642 related articles for article (PubMed ID: 26213370)
1. Heterogeneity of liver cancer and personalized therapy.
Li L; Wang H
Cancer Lett; 2016 Sep; 379(2):191-7. PubMed ID: 26213370
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in hepatocellular carcinoma: An update.
Niu ZS; Niu XJ; Wang WH
World J Gastroenterol; 2016 Nov; 22(41):9069-9095. PubMed ID: 27895396
[TBL] [Abstract][Full Text] [Related]
3. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
4. Personalized therapy for hepatocellular carcinoma: Where are we now?
Chan SL; Wong AM; Lee K; Wong N; Chan AK
Cancer Treat Rev; 2016 Apr; 45():77-86. PubMed ID: 26995632
[TBL] [Abstract][Full Text] [Related]
5. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
8. Precision diagnosis and treatment of liver cancer in China.
Fu J; Wang H
Cancer Lett; 2018 Jan; 412():283-288. PubMed ID: 29050983
[TBL] [Abstract][Full Text] [Related]
9. Personalized targeted therapy for esophageal squamous cell carcinoma.
Kang X; Chen K; Li Y; Li J; D'Amico TA; Chen X
World J Gastroenterol; 2015 Jul; 21(25):7648-58. PubMed ID: 26167067
[TBL] [Abstract][Full Text] [Related]
10. Drug sensitivity testing platforms for gastric cancer diagnostics.
Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
[TBL] [Abstract][Full Text] [Related]
11. Genetics of hepatobiliary carcinogenesis.
Nault JC; Zucman-Rossi J
Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma.
Klungboonkrong V; Das D; McLennan G
J Vasc Interv Radiol; 2017 Jul; 28(7):949-955. PubMed ID: 28416267
[TBL] [Abstract][Full Text] [Related]
13. A precision, personalized approach to the management of bladder cancer.
Apolo AB; Burger M
Curr Opin Urol; 2015 Sep; 25(5):416-7. PubMed ID: 26153639
[No Abstract] [Full Text] [Related]
14. Precision and predictive medicine in urothelial cancer: are we making progress?
Bellmunt J; Orsola A; Sonpavde G
Eur Urol; 2015 Oct; 68(4):547-9. PubMed ID: 25935702
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
[TBL] [Abstract][Full Text] [Related]
16. New insights into molecular diagnostic pathology of primary liver cancer: Advances and challenges.
Cong WM; Wu MC
Cancer Lett; 2015 Nov; 368(1):14-19. PubMed ID: 26276723
[TBL] [Abstract][Full Text] [Related]
17. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
[TBL] [Abstract][Full Text] [Related]
18. "Hepatocellular carcinoma: A life-threatening disease".
Chacko S; Samanta S
Biomed Pharmacother; 2016 Dec; 84():1679-1688. PubMed ID: 27823920
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
[TBL] [Abstract][Full Text] [Related]
20. Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer.
Rao CV; Asch AS; Yamada HY
Carcinogenesis; 2017 Jan; 38(1):2-11. PubMed ID: 27838634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]